Neuregulin 1-ErbB4 signaling in the bed nucleus of the stria terminalis regulates anxiety-like behavior

Neuroscience. 2016 Aug 4:329:182-92. doi: 10.1016/j.neuroscience.2016.05.018. Epub 2016 May 14.

Abstract

The bed nucleus of the stria terminalis (BNST), a nucleus defined as part of the extended amygdala, is involved in the expression of anxiety disorders. However, the regulatory mechanisms of BNST inhibitory activity that is involved in anxiety are unknown. Here, we showed that blocking neuregulin 1 (NRG1)-ErbB4 signaling in the BNST of mice, by either neutralizing endogenous NRG1 with ecto-Erbb4 or antagonizing the ErbB4 receptor with its specific inhibitor, produced anxiogenic responses. Interestingly, application of exogenous NRG1 into the BNST induced no anxiolytic effects, suggesting saturating activity of endogenous NRG1. While infusion of the GABAA receptor antagonist bicuculline into the BNST also led to anxiety-related behaviors, it did not worsen the anxiogenic effects produced by blocking NRG1-ErbB4 signaling, suggesting possible involvement of GABAergic neurotransmission. Further, in vitro electrophysiological recordings showed that BNST NRG1-ErbB4 signaling regulated the presynaptic GABA release. Together, these results suggest that NRG1-ErbB4 signaling in the BNST may play an important role in regulating anxiety-like behaviors.

Keywords: BNST; ErbB4; GABAergic neurotransmission; NRG1; anxiety.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Anxiety / metabolism*
  • Bicuculline / pharmacology
  • Central Nervous System Agents / pharmacology
  • GABA-A Receptor Antagonists / pharmacology
  • Male
  • Membrane Potentials / drug effects
  • Membrane Potentials / physiology
  • Mice, Inbred C57BL
  • Models, Animal
  • Neuregulin-1 / administration & dosage
  • Neuregulin-1 / antagonists & inhibitors
  • Neuregulin-1 / metabolism*
  • Presynaptic Terminals / drug effects
  • Presynaptic Terminals / metabolism
  • Pyrimidines / pharmacology
  • Receptor, ErbB-4 / antagonists & inhibitors
  • Receptor, ErbB-4 / metabolism*
  • Receptors, GABA-A / metabolism
  • Septal Nuclei / drug effects
  • Septal Nuclei / metabolism*
  • Tissue Culture Techniques
  • gamma-Aminobutyric Acid / metabolism

Substances

  • 6-(methylamino)pyrido(3,4-d)pyrimidine
  • Central Nervous System Agents
  • GABA-A Receptor Antagonists
  • Neuregulin-1
  • Nrg1 protein, mouse
  • Pyrimidines
  • Receptors, GABA-A
  • gamma-Aminobutyric Acid
  • Erbb4 protein, mouse
  • Receptor, ErbB-4
  • Bicuculline